Connect with us

Cannabis News

Over 30% of Cannabis Businesses May Permanently Close If No COVID-19 Stimulus Relief



Coronavirus Quarantines Lead Parents to Seek Stress Relief With Cannabis

According to a new survey conducted on state-licensed cannabis companies, 1 in 3 such businesses may permanently close and not receive any federal COVID-19 relief. This would also mean all facets of the weed industry that rely on various provided services such as testing and tracking, cultivation of plants, distribution, packaging, product marketing of weed would also be affected. The national survey was conducted on 483 cannabis businesses and conducted for almost 3 weeks between the end of April and the first week of May. Just over eighty percent of the surveyed companies said they would have to start firing employees if they don’t get a federal bailout like other businesses in the US did. The National Cannabis Roundtable (NCR), which is a trade association fighting for the legalization of marijuana, and Leafly, together conducted the survey.

243,000 People Hired in the Cannabis Industry Back in February

The cannabis industry in the US hired 243,000 people back in February, giving them entrance to a $10.7 billion market, says a Leafly Cannabis Jobs Report. However, since then, 58% of pot businesses have decided to operate with their staff significantly reduced, which is a problem in all US industries, not only the cannabis one. Here’s what Saphira Galoob, the executive director of NCR, had to say about this:

“Before this crisis began, the cannabis industry represented the fastest growing jobs market in the US, despite restrictions on access to banking services.”

Marijuana Business Can’t be Conducted with Banks

While there’s a proposed federal bill saying banks should offer business accounts, loans and credit loans to marijuana operators, these marijuana businesses cannot work with big banks because marijuana is federally outlawed. Cannabis companies paid out over 4 Billion in federal taxes just 3 years ago. These taxes paid by weed and cannabis companies may provide much needed funds towards losses with the US Congress approving yet another COVID-19 stimulus relief package worth trillions of dollars.

In the case that one third of the American weed industry gives up on conducting business altogether, these losses are going to be drastically felt in consumers personal incomes, transactions, tax revenue and even employment. As an irony, 8 states have deemed the marijuana businesses to be essential during the Coronavirus pandemic, so dispensaries or cultivation sites wouldn't be closed. Some other of the essential businesses included are pharmacies, grocery and gun shops. However, ironically the US government and the Republicans in the Senate in particular think the weed industry shouldn’t receive federal relief even though they pay taxes. It’s good to know that there are some Democrats fighting to include some of the cannabis state-licensed companies in this next federal stimulus relief funding round.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.